Parkinson's & Movement disorders

Long-term use of isradipine does not slow Parkinson's progression

Long-term treatment with immediate-release isradipine does not seem to slow the clinical progression of early-stage Parkinson's disease. Findings from a multicenter, randomized, parallel-group, double-blind, placebo-controlled ...

Neuroscience

Alzheimer's risk genes converge on microglia

DNA determines a large part of the risk for Alzheimer's disease, but it remained unclear how many genetic risk factors contribute to disease. A team led by Prof. Bart De Strooper (VIB-KU Leuven) and Dr. Mark Fiers now show ...

Neuroscience

Antidepressant harms baby neurons in lab-grown 'mini-brains'

Researchers at Johns Hopkins Bloomberg School of Public Health have demonstrated the use of stem-cell-derived "mini-brains" to detect harmful side effects of a common drug on the developing brain. Mini-brains are miniature ...

page 2 from 19